🔎 Trials Near Me

Home › Liver Diseases › Pennsylvania › Philadelphia

Liver Diseases clinical trials in Philadelphia, PA

6 studies for Liver Diseases are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

RecruitingPhase 3
  • 89bio Clinical Study Site, Philadelphia
Ages 18 to 75 · All sexes · Updated Oct 5, 2026 · NCT06419374

Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

RecruitingPhase 3
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University, Dept of Radiology, Philadelphia
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05470205

Primary Sclerosing Cholangitis in Children

RecruitingObservational study
  • The Children's Hospital of Philadelphia, Philadelphia
Ages 2 to 25 · All sexes · Updated Jul 14, 2026 · NCT04181138

DILIN - Prospective Study

RecruitingObservational studyHealthy volunteers welcome
  • Thomas Jefferson, Philadelphia
Ages 2 and older · All sexes · Updated Apr 8, 2026 · NCT00345930

A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease

Recruiting
  • Albert Einstein Healthcare Network, Philadelphia
Ages 18 and older · All sexes · Updated Oct 24, 2025 · NCT05733832

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

RecruitingObservational study
  • Children's Hospital of Philadelphia, Philadelphia
All ages · All sexes · Updated May 25, 2025 · NCT06193928

About Liver Diseases

Get the facts about liver diseases, such as hepatitis, cancer, and cirrhosis. Know your risk and what you can do to prevent liver problems.

More about Liver Diseases on MedlinePlus

Liver Diseases trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.